ProLungdx Board Names Dr. John C. Ruckdeschel As Newest Board Member

SALT LAKE CITY--(BUSINESS WIRE)--The Board of Directors of Fresh Medical Laboratories Inc., doing business as ProLungdx, today announced the appointment of Dr. John C. Ruckdeschel, M.D., to serve as a Director on the Company’s Board of Directors. Dr. Ruckdeschel is a renowned oncologist with a career-long focus on thoracic malignancies and lung cancer. Dr. Ruckdeschel formerly served as the Medical Director of Clinical Oncology at Intermountain Healthcare in Salt Lake City, Utah, the CEO of Moffitt Cancer Center and is a current member of the Medical Advisory Board of ProLungdx.
MORE ON THIS TOPIC